DCM
DAFNA Capital Management’s Corbus Pharmaceuticals CRBP Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2020
Q3 | – | Sell |
-108,061
| Closed | -$907K | – | 83 |
|
2020
Q2 | $907K | Sell |
108,061
-639,239
| -86% | -$5.37M | 0.26% | 60 |
|
2020
Q1 | $3.92M | Buy |
747,300
+450,000
| +151% | +$2.36M | 1.63% | 18 |
|
2019
Q4 | $1.62M | Hold |
297,300
| – | – | 0.56% | 44 |
|
2019
Q3 | $1.45M | Hold |
297,300
| – | – | 0.54% | 48 |
|
2019
Q2 | $2.06M | Sell |
297,300
-7,700
| -3% | -$53.4K | 0.77% | 36 |
|
2019
Q1 | $2.12M | Buy |
305,000
+150,000
| +97% | +$1.04M | 0.91% | 33 |
|
2018
Q4 | $905K | Buy |
+155,000
| New | +$905K | 0.45% | 51 |
|
2016
Q3 | – | Sell |
-400,000
| Closed | -$1.2M | – | 85 |
|
2016
Q2 | $1.2M | Buy |
+400,000
| New | +$1.2M | 0.95% | 38 |
|
2015
Q4 | – | Sell |
-50,000
| Closed | -$79K | – | 80 |
|
2015
Q3 | $79K | Buy |
50,000
+13,410
| +37% | +$21.2K | 0.08% | 83 |
|
2015
Q2 | $113K | Buy |
+36,590
| New | +$113K | 0.1% | 72 |
|